Evidence map›Paper›PMID 37183226›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2023

Determination of metronidazole and clarithromycin in plasma samples using surfactant-modified amorphous carbon-based DSPE combined with DLLME followed by HPLC.

Faezeh Javanbakht, Mohammad Reza Afshar Mogaddam, Mahboob Nemati, Mir Ali Farajzadeh, Aysa Abbasalizadeh

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Faezeh JavanbakhtStudent Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad Reza Afshar MogaddamFood and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mr.afsharmogaddam@yahoo.com.
Mahboob NematiPharmaceutics and Food Department, Tabriz University of Medical Sciences, Tabriz, Iran. nematim@tbzmed.ac.ir.
Mir Ali FarajzadehDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Aysa AbbasalizadehDepartment of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Tabriz University of Medical Sciences · IRNear East University · CYUniversity of Tabriz · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work offers preparation of surfactant-modified amorphous carbon and its application in dispersive solid phase extraction of metronidazole and clarithromycin from plasma samples. The extraction procedure was combined with dispersive liquid-liquid microextraction for further preconcentration of the analytes for sensitive determination of the analytes followed by high performance liquid chromatography-diode array detector. In this work, first, the sorbent was added to the sample and the mixture vortexed to adsorb the analytes. Then, the obtained supernatant after centrifuging is discarded and the loaded analytes onto the sorbent surface were eluted with a water-miscible organic solvent. In the following, to further enrichment of the analytes the microextraction step was done. For this purpose, the eluate is taken, mixed with a water-immiscible organic solvent, and injected into deionized water. After centrifuging, an aliquat of the sedimented phase is taken and injected into the analytical instrument for the quantitative analysis. Under the optimum extraction conditions, high extraction recoveries (79 and 89% for metronidazole and clarithromycin, respectively), low limits of detection (2.1 and 1.9 ng mL

Indexed as

ClarithromycinMetronidazoleCarbonChromatography, High Pressure LiquidHumansPhosphatidylethanolaminesSolventsSurface-Active AgentsWater1,2-distearoylphosphatidylethanolamineCarbonClarithromycinMetronidazolePhosphatidylethanolaminesSolventsSurface-Active AgentsWaterClarithromycinDispersive solid phase extractionHigh-performance liquid chromatographyMetronidazolePlasma

Identifiers

PMID37183226
OpenAlexW4376630895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.